Barclays PLC Sells 316,718 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Barclays PLC lowered its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 92.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,709 shares of the company’s stock after selling 316,718 shares during the period. Barclays PLC owned approximately 0.18% of U.S. Physical Therapy worth $2,261,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of USPH. Precision Wealth Strategies LLC boosted its stake in U.S. Physical Therapy by 5.1% during the 3rd quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock worth $239,000 after acquiring an additional 137 shares during the last quarter. Louisiana State Employees Retirement System grew its holdings in shares of U.S. Physical Therapy by 2.7% in the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $702,000 after buying an additional 200 shares during the period. Martin Capital Advisors LLP grew its holdings in shares of U.S. Physical Therapy by 1.6% in the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock valued at $1,112,000 after buying an additional 201 shares during the period. First Horizon Advisors Inc. increased its position in shares of U.S. Physical Therapy by 25.1% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock valued at $126,000 after buying an additional 298 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new stake in U.S. Physical Therapy during the 2nd quarter worth $28,000.

Insider Activity

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.72, for a total value of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares in the company, valued at $107,552.64. This trade represents a 51.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,412 shares of company stock worth $706,605 in the last quarter. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $90.26 on Thursday. The stock has a market capitalization of $1.36 billion, a price-to-earnings ratio of 96.02, a PEG ratio of 4.23 and a beta of 1.46. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63. The firm has a fifty day simple moving average of $91.25 and a 200 day simple moving average of $89.56. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were paid a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.95%. U.S. Physical Therapy’s dividend payout ratio is 187.23%.

Analysts Set New Price Targets

USPH has been the subject of several recent analyst reports. JMP Securities initiated coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target for the company. JPMorgan Chase & Co. increased their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. Barrington Research reissued an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Finally, Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $100.00 to $115.00 in a research report on Monday, December 16th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $114.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.